-
EP3191527
European procedure
Extract from the Register of European Patents
EP Citations: EP3191527
| Cited in | International search | Type: | Patent literature | Publication No.: | WO2008083150
[X] (CENTOCOR INC et al.) | Type: | Patent literature | Publication No.: | WO9730087
[X] (GLAXO GROUP LTD et al.) | Type: | Patent literature | Publication No.: | FR2861080
[X] (LAB FRANCAIS DU FRACTIONNEMENT et al.) [X] 1,3,6,13 * example -; table 1 * | Type: | Patent literature | Publication No.: | WO2013021279
[X] (LFB BIOTECHNOLOGIES et al.) [X] 8,9,14,17,18,21,22 * page 30, li 23;; example - * | Type: | Non-patent literature | Publication information: | [X] DAMIAN HOUDE ET AL: "Post-translational modifications differentially affect IgG1 conformation and receptor binding", MOLECULAR & CELLULAR PROTEOMICS : MCP, 1 August 2010 (2010-08-01), United States, pages 1716 - 1728, XP055169032, Retrieved from the Internet | DOI: | http://dx.doi.org/10.1074/mcp.M900540-MCP200 | Type: | Non-patent literature | Publication information: | [XY] SHINKAWA T ET AL: "The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, vol. 278, no. 5, 31 January 2003 (2003-01-31), pages 3466 - 3473, XP002355427, ISSN: 0021-9258, DOI: 10.1074/JBC.M210665200 [X] 1,2,4,13-15,17,18,21,22 * figure 1B; table I *[Y] 1-23 | DOI: | http://dx.doi.org/10.1074/jbc.M210665200 | Cited in | other | Type: | Non-patent literature | Publication information: | ANONYMOUS: "Afucosylated monoclonal antibodies", WIKIPEDIA, THE FREE ENCYCLOPEDIA, 8 December 2018 (2018-12-08), XP055566770, Retrieved from the Internet | Type: | Non-patent literature | Publication information: | ANONYMOUS: "PNGase F", WIKIPEDIA, THE FREE ENCYCLOPEDIA, XP03042018, Retrieved from the Internet |